You are hereHome >
In the news
People in Illinois with various medical conditions have had to fork over 10 times more on average than what’s necessary for at least 20 brand name drugs, according to a report from Illinois PIRG and Community Catalyst.
Costs for these 20 drugs, including Lipitor and Cipro, were kept high, because brand name pharmaceutical companies paid generic makers to keep cheaper versions off the market for a time. These agreements are known as “pay for delay.”
“It’s outrageous that drug companies are paying off the competition to keep prices high,” said Illinois PIRG State Director Brian Imus in a statement. “Because of this, people in Illinois pay inflated drug prices, or go without necessary medication. This needs to stop.”
Defend the CFPB
Tell your senators to oppose the “Financial CHOICE Act,” which would gut Wall Street reforms and destroy the Consumer Financial Protection Bureau as we know it.
Your donation supports Illinois PIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.